In a clinical trial, the Institutional Review Board (IRB) requires that participants be informed of all potential risks, that participation be voluntary, and that participants can withdraw at any time. These requirements collectively ensure
- Athat the study has a large enough sample size
- Bthat the results can be generalized to the entire population
- Cthat the study uses random assignment to treatment groups
- Dinformed consent, which protects the rights and welfare of research participantsCorrect
Why D is right
The three requirements described — disclosure of risks, voluntary participation, and the right to withdraw — are the core components of informed consent. Informed consent is an ethical requirement that protects research participants by ensuring they understand what the study involves and freely agree to participate. This is mandated by ethical guidelines such as the Belmont Report.
Why the other 3 choices miss
- A
- Incorrect. Sample size is a statistical consideration determined by power analysis. Informed consent requirements do not address sample size.
- B
- Incorrect. Generalizability depends on the sampling method and study design, not on informed consent procedures. Informed consent protects participants, not the external validity of the study.
- C
- Incorrect. Random assignment is a design feature of experiments. While ethical review may examine the design, informed consent specifically addresses participant rights, not treatment allocation.